Controlled release of proteins to tissue transplants for the treatment of neurodegenerative disorders

被引：49

作者：

Mahoney, MJ ^{[1
]}

Saltzman, WM ^{[1
]}

机构：

[1] JOHNS HOPKINS UNIV, DEPT CHEM ENGN, BALTIMORE, MD 21218 USA

来源：

JOURNAL OF PHARMACEUTICAL SCIENCES | 1996年 / 85卷 / 12期

基金：

美国国家航空航天局;

关键词：

D O I：

10.1021/js9601602

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Alzheimer's disease involves substantial cholinergic cell deficits; other neurodegenerative diseases involve similar losses of certain cell populations. Optimal therapies may involve tissue replacement coupled with the controlled delivery of appropriate growth factors, such as nerve growth factor, to the graft site. In this review article we describe the kinetics of protein release from three modes of controlled protein delivery to transplants: delivery from a polymer matrix, delivery form polymeric microspheres, and delivery from genetically engineered cells. The efficacy and feasibility of each of these delivery strategies for potential treatment of patients diagnosed with neurodegenerative disorders is discussed.

引用

页码：1276 / 1281

页数：6

共 46 条

[1] TRANSPLANTATION OF NEURAL TISSUE IN POLYMER CAPSULES [J].

AEBISCHER, P ;

WINN, SR ;

GALLETTI, PM .

BRAIN RESEARCH, 1988, 448 (02) :364-368

[2] BIODEGRADABLE MICROSPHERES AS CONTROLLED-RELEASE TETANUS TOXOID DELIVERY SYSTEMS [J].

ALONSO, MJ ;

GUPTA, RK ;

MIN, C ;

SIBER, GR ;

LANGER, R .

VACCINE, 1994, 12 (04) :299-306

[3]

BLASBERG RG, 1975, J PHARMACOL EXP THER, V195, P73

[4] SUSTAINED-RELEASE OF NERVE GROWTH-FACTOR FROM BIODEGRADABLE POLYMER MICROSPHERES [J].

CAMARATA, PJ ;

SURYANARAYANAN, R ;

TURNER, DA ;

PARKER, RG ;

EBNER, TJ .

NEUROSURGERY, 1992, 30 (03) :313-319

[5]

CLELAND JL, 1995, VACCINE DESIGN SUBUN, P439

[6] CONTROLLED DELIVERY SYSTEMS FOR PROTEINS BASED ON POLY(LACTIC GLYCOLIC ACID) MICROSPHERES [J].

COHEN, S ;

YOSHIOKA, T ;

LUCARELLI, M ;

HWANG, LH ;

LANGER, R .

PHARMACEUTICAL RESEARCH, 1991, 8 (06) :713-720

[7]

DELUCA PP, 1993, ACS SYM SER, V520, P53

[8] CONTROLLED VACCINE RELEASE IN THE GUT-ASSOCIATED LYMPHOID-TISSUES .1. ORALLY-ADMINISTERED BIODEGRADABLE MICROSPHERES TARGET THE PEYERS PATCHES [J].

ELDRIDGE, JH ;

HAMMOND, CJ ;

MEULBROEK, JA ;

STAAS, JK ;

GILLEY, RM ;

TICE, TR .

JOURNAL OF CONTROLLED RELEASE, 1990, 11 (1-3) :205-214

[9] IMPLANTATION OF POLYMER-ENCAPSULATED HUMAN NERVE GROWTH FACTOR-SECRETING FIBROBLASTS ATTENUATES THE BEHAVIORAL AND NEUROPATHOLOGICAL CONSEQUENCES OF QUINOLINIC ACID INJECTIONS INTO RODENT STRIATUM [J].

EMERICH, DF ;

HAMMANG, JP ;

BAETGE, EE ;

WINN, SR .

EXPERIMENTAL NEUROLOGY, 1994, 130 (01) :141-150

[10] IMPLANTS OF POLYMER-ENCAPSULATED HUMAN NGF-SECRETING CELLS IN THE NONHUMAN PRIMATE - RESCUE AND SPROUTING OF DEGENERATING CHOLINERGIC BASAL FOREBRAIN NEURONS [J].

EMERICH, DF ;

WINN, SR ;

HARPER, J ;

HAMMANG, JP ;

BAETGE, EE ;

KORDOWER, JH .

JOURNAL OF COMPARATIVE NEUROLOGY, 1994, 349 (01) :148-164

← 1 2 3 4 5 →